
HUMASIS CO., LTD. — Investor Relations & Filings
Humasis Co., Ltd. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) devices, with a primary focus on Point-of-Care Testing (POCT). The company develops and produces a range of rapid diagnostic solutions, including immunodiagnostic kits for the early screening of various diseases, compact instruments for quantitative analysis, and personal health care products. A key operational strength is the in-house development and production of critical bio-materials, such as diagnostic immune antigens, which ensures the consistent performance and accuracy of its products. Humasis aims to provide technologies for precise and rapid disease analysis to support clinical decision-making and promote individual health management.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주식등의대량보유상황보고서(일반) | 2026-05-22 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-22 | Korean | |
| 최대주주변경 | 2026-05-18 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2026-05-15 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-15 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46784499 | 주식등의대량보유상황보고서(일반) | 2026-05-22 | Korean | ||
| 46784491 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-22 | Korean | ||
| 46383060 | 최대주주변경 | 2026-05-18 | Korean | ||
| 46367906 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 46363542 | 주식등의대량보유상황보고서(일반) | 2026-05-15 | Korean | ||
| 46363047 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-15 | Korean | ||
| 44166571 | 주권매매거래정지해제 (액면병합 주권 변경상장) | 2026-05-08 | Korean | ||
| 39078655 | 소속부변경 | 2026-04-30 | Korean | ||
| 35626755 | 주식등의대량보유상황보고서(일반) | 2026-04-23 | Korean | ||
| 35626726 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-23 | Korean | ||
| 35626668 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-23 | Korean | ||
| 33898415 | 주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소) | 2026-04-09 | Korean | ||
| 33892892 | 기타경영사항(자율공시) | 2026-04-09 | Korean | ||
| 33890911 | 임원ㆍ주요주주특정증권등거래계획보고서 | 2026-04-09 | Korean | ||
| 33691395 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-07 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
HUMASIS CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15964/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15964 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15964 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15964 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15964}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HUMASIS CO., LTD. (id: 15964)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.